In addition to our LGSC cohort, we also report here are a small number of serous carcinoma cases with coinciding RAS and TP53 mutations, all of which were high grade-like in their genomic characteristics (Supplementary Figures S3 and S4). Here, TP53 is linked to serous adenocarcinoma.